New Formulation of Rotarix Removes the Need for Reconstitution
The new liquid formulation of Rotarix does not require reconstitution or dilution before use.
Diagnosis & Disease Information
Routine Vaccination Coverage Decreased in 2021 Worldwide
Coverage levels for three doses of DTP-containing vaccine, measles-containing vaccine down to lowest levels since 2008
MPR Weekly Dose Podcast #137
USPSTF recommendations on estrogen and progesterone; semaglutide assessed in obese teenagers; efficacy and safety data released for investigational maternal RSV vaccine; updates to Clozapine REMS; FDA panel votes on investigational CNS/leptomeningeal metastasis treatment.
Semaglutide Reduces BMI More Than Lifestyle Changes in Teens With Obesity
Semaglutide is a glucagon-like peptide-1 receptor agonist.
October 2022 Recap: Drug Pipeline Updates
The table provided is a review of notable updates that occurred in October 2022 for investigational products in development.
Maternal RSV Vaccine Candidate Provides Protection for Infants in Phase 3 Trial
The RSVpreF vaccine candidate consists of 2 prefusion F proteins selected to optimize protection against RSV A and B.
Maternal Caffeine Consumption Linked to Smaller Child Height
Children of women in fourth versus first quartile of plasma caffeine concentration had lower height z scores
ASA: Less Noise May Aid Children’s Behavior Following General Anesthesia
Postoperative benefits seen for mood, eating, and engagement
Overall Symptoms After BNT162b2, Other Vaccines Comparable in Younger Children
Injection-site, musculoskeletal, dermatologic, otolaryngologic symptoms more frequent; general symptoms and fever less frequent with BNT162b2 in children younger than 5 years of age
Lirentelimab Efficacious, Safe for Patients With Eosinophilic Esophagitis
The first group received high-dose lirentelimab for 24 weeks. The second group received low-dose lirentelimab, while the placebo group received 6 monthly infusions during the 24-week study.
